• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    More On POH.AX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Phosphagenics Limited (POH.AX)

    -ASX
    0.02 Up 0.00(4.55%) Jul 3, 1:56AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Phosphagenics Limited
    11 Duerdin Street
    Clayton, VIC 3168
    Australia - Map
    Phone: 61 3 9565 1119
    Fax: 61 3 9565 1151
    Website: http://www.phosphagenics.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:41

    Business Summary 

    Phosphagenics Limited, a research-based biotechnology company, produces, sells, and licenses products for the pharmaceutical, cosmetics, and animal health industries. The company is involved in the commercialization of therapeutic products using its targeted penetration matrix technology, a drug delivery system that enhances human and animal health. Its Skin Care segment provides a range of products to enhance the appearance of skin. The company’s Pain Portfolio segment focuses on enhancing the delivery of opioids used for pain treatment through the skin. It serves customers in Australia, Switzerland, the United States, India, Brazil, and other countries. The company was formerly known as Vital Capital Limited and changed its name to Phosphagenics Limited in 2004. Phosphagenics Limited is based in Clayton, Australia.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Phosphagenics Limited

    Key Executives 
     PayExercised
    Mr. Harry Rosen BA, LLB, 67
    Founder and Exec. Director
    N/AN/A
    Ms. Anna Legg ,
    Chief Financial Officer
    N/AN/A
    Dr. Paul Gavin BSc (Hons), Ph.D.,
    Chief Scientific Officer
    N/AN/A
    Mr. Jason J. Rosen ,
    Gen. Counsel
    N/AN/A
    Mr. Alex Stojanovic ,
    VP of Bus. Devel. & Commercial Operations
    272.00KN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in AUD.